You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
無視風險提示,玻尿酸概念魯商發展(600223.SH)連續第5日漲停
格隆匯 10-24 10:00
格隆匯10月24日丨在四個漲停板後,被冠上“玻尿酸概念”的魯商發展(600223.SH)今日繼續漲停,報6.64元,暫成交1735萬元,漲停封單逾83萬手,最新總市值66.46億元。該股在最近15個交易日內累計漲幅達93%。由於近日有兩家玻尿酸公司將登陸A股科創板,分別是華熙生物和昊海生科。招股書數據顯示,兩家公司的主營業務毛利率均超過75%,昊海生科2018年的玻尿酸產品毛利率更是高達93.26%。由此,A股市場的玻尿酸概念股提前反應。而早在去年12月將玻尿酸龍頭之一的企業福瑞達納入公司版圖的魯商發展成為市場關注焦點。不過,10月23日,公司發佈風險提示公告稱,公司醫藥、化粧品等非地產類業務2019年上半年實現營業收入4.98億元,佔公司營業收入的12.4%,實現歸屬於母公司所有者的淨利潤0.29億元,佔公司淨利潤的28.72%,對公司的營業收入和淨利潤貢獻相對較小,不會對公司近期經營業績產生較大影響,公司目前的主營業務仍為房地產。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account